All splenic myelopoiesis articles
-
NewsBacterial nanoplatform targets spleen to reprogram immune cells and prevent cancer recurrence
Researchers have announced the development of an engineered nanoplatform named t-SMC, which precisely targets the spleen to reverse splenic myelopoiesis toward an antitumoral immune phenotype.